Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Study: New Engineered Particles Train the Body to Accept Allergens

FDA Delays Approval of Aquestive’s Anaphylm™ Sublingual Epinephrine Film

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

Aptar Pharma and BD Announce Deal to Bring New Auto-Injector to...

Pharmaceutical Company Developing Inhalable Epinephrine

Recap: Four Auto-Injectors on the Horizon

Promising OIT Results from UNC Phase II Trial

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

Epinephrine Auto-injectors: Where is the Long Promised Generic?

Adamis Auto-Injector Rejected by FDA

Delivering the Next Generation Auto-Injector

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

Nestlé Partners with DBV to Develop Milk Allergy Test

Your School On Our Map

Put Your School on the Map